cyc 202 has been researched along with morphine in 5 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | cyc 202 (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, YJ; Lee, TH; Liu, JK; Lu, CY; Tsai, YJ; Wang, CH; Yang, LC | 1 |
| Nagumo, Y; Narita, M; Shibasaki, M; Suzuki, T; Yajima, Y | 1 |
| Beaudry, H; Delaygue, C; Gendron, L; Lavoie, C; Mercier-Blais, AA; Neugebauer, W; Parent, JL | 1 |
5 other study(ies) available for cyc 202 and morphine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Intrathecal cdk5 inhibitor, roscovitine, attenuates morphine antinociceptive tolerance in rats.
Topics: Analgesics, Opioid; Animals; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Drug Tolerance; Injections, Spinal; Male; Morphine; Pain Measurement; Pain Threshold; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2004 |
Implication of cyclin-dependent kinase 5 in the development of psychological dependence on and behavioral sensitization to morphine.
Topics: Animals; Behavior, Animal; Brain Chemistry; Cyclin-Dependent Kinase 5; Cyclin-Dependent Kinases; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Female; Gyrus Cinguli; Male; Mice; Mice, Knockout; Morphine; Morphine Dependence; Narcotics; Neuronal Plasticity; Phosphorylation; Purines; Reward; Roscovitine; Up-Regulation | 2005 |
Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5.
Topics: Analgesia; Animals; Cell-Penetrating Peptides; Cyclin-Dependent Kinase 5; Drug Interactions; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Ganglia, Spinal; Lipopeptides; Male; MAP Kinase Signaling System; Morphine; Oligopeptides; Pain Measurement; Purines; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu; Roscovitine | 2015 |